611 S. Carlin Springs Road, Suite 411 Arlington, VA 22204
After just one session there was a noticible tightening to my jawline. Tripollar works by heating the skin to a certain temperature for a duration of time to create changes to the dermis. Of course it takes time to build up more and more collagen so more treatments will give your results longevity.
–Suzanne Donithan/Medical Aesthetician
Treating acne can be a lifelong struggle and for many individuals it can feel like there is no end to the blackheads, whiteheads or pimples. Fortunately, all these issues are perfectly treatable and, when addressed correctly, can be cleared with relative ease.
There are many ways to address acne effectively. When seeking the best acne treatment, it’s best to remember that not all acne is the same. With 4 different variations of acne ranging from mild to cystic, finding a good balance for the skin is key.
Home is one of the best places to start treating acne. Controlling oil production and staying away from comedogenic products are two of the best, and cheapest, ways to avoid pore blockage and infection. However, be careful not to over-strip the skin with excessive cleaning as this can cause an overproduction of oil in the sebaceous glands.
For those seeking a more professional touch, a popular acne treatment amongst dermatologists is salicylic acid. This topical peels and infuses the skin and, depending on how deep the acne resides, can be very effective. However, regular maintenance is vital. Keep the skin clean and gently exfoliate on a regular basis.
More serious acne conditions may require the use of medication. While these prescription creams can produce effective results, they can occasionally be harsh and drying to the skin. In order to counteract these side-effects, keep the skin hydrated and calm to reduce redness.
Additionally, never attempt to extract acne at home. Improper removal of dirt, oil and bacteria filling an infected pore can lead to further infection and skin damage. Always let a trained professional sterilely extract acne in order to reduce injury and prevent scarring.
Chemical peeling is one of the most effective methods to, literally, reverse signs of aging from the skin.
While there are many different ways to peel the skin, one of the most effective ways is through the use of chemical peels. A chemical peel dramatically assists in the removal of dead cells on the surface of your skin making way for cell renewal and absorption of topicals.
Chemical peels are used specifically to address:
Generally, deeper peels are done in a dermatologist office using phenol and TCA or a mixture of acids. Lighter chemical peels can be done by a trained esthetician using lactic, glycolic, salicylic and other alpha-hydroxyl and beta-hydroxyl acids.
Dr. Alan Terlinsky is proud to announce the arrival of the new Verjú Cellulite device using Low-Level-Laser-Therapy at his Nu-living Optimal Wellness and Longevity Center located in Arlington, VA. Dr. Terlinsky’s practice will be the first office in Metropolitan Washington DC and Northern VA to use the novel Verjú technology which, after an impressive scientific study, has been recently approved by the FDA for safety and efficacy in permanent cellulite removal.
Dr Terlinsky notes that the cutting edge Verjú, was developed by Erchonia Inc, an innovator and leader in producing medical lasers for treating various conditions such as chronic musculo-skeletal pain, acne, and facial wrinkles. Erchonia is best known for its famous non-invasive Low-Level-Laser-Therapy devices using a cold “red“ laser, the Zerona and Zerona AD. Both are FDA approved for body slimming, contouring and sculpting. Application of the Zerona laser dissolves fat from hips, waist, thighs, abdomen and arms resulting in a reduction of 1-2 pants or dress sizes in a matter of a few weeks.
Erchonia has now tested and released a new, more advanced device using Low-Level-Laser-Therapy technology called the Verjú. The Verjú is a Low-Level-Laser-Therapy device using a cold “green” laser and the Zerona, a Low-Level-Laser-Therapy device using a cold “red”” laser. Both the Verjú and the Zerona lasers are non-thermal and produce no heat, so patients do not feel anything while the procedure is performed. The Verjú, is more powerful than the Zerona, and not only dissolves fat, but it can break up fibrous tissue, tighten skin and stimulate new collagen deposition. These unique treatment effects are central to non-invasively and painlessly resolving the displeasing aesthetic appearance of cellulite.
Verjú treatments are typically 30 minutes long, and average two weeks to three weeks in length. Dr Terlinsky says, “we can pinpoint the body areas which require customized treatment. We configure the Verjú to treat problematic areas in the midsection, buttocks, and thighs. We are able to treat those areas most annoying to the patients and often resistant to all other non-surgical treatments.” “It’s very simple”, as Dr Terlinsky relates, “Patients are given a menu from which they can merely indicate their desired body area priorities to improve skin appearance.”
In a recent clinical trial, not only did the Verjú laser system allow permanent cellulite removal, but pre and post measurements showed the Verjú also significantly reduced the circumference of the thighs. In just two weeks with six treatments with the Verjú cellulite laser, patients experienced significant improvement in the appearance of cellulite in their thighs, buttocks, and lower abdomen when compared with those treated with the placebo laser.
According to Dr Terlinsky, “Studies performed on the Verjú have shown that, in contrast to other available non-invasive technologies, Verjú is, safe and effective as a stand alone procedure for significantly improving the appearance of cellulite after only two weeks.” Dr. Terlinsky notes that the Verjú produced excellent results without any other adjuvant therapy such as massage, mechanical manipulation special diet, exercise, topical preparations, or medications. Verjú is unique among cellulite treatments in not requiring adjuvant treatments.
As patients come to the Nu-living Optimal Wellness and Longevity Center and undergo Verjú cellulite treatment, Dr Terlinsky says, “Patients will benefit from the scientifically proven Verjú cellulite procedure. Before the publication of the Verjú study, there had been no definitive, non-invasive proven treatment approach for cellulite which scientifically has been demonstrated to resolve or significantly improve the distressing cellulite effect. Unlike the enduring Verjú effect, many existing therapies fail to create improvements which last.”
It is most important to begin to answer this question by stating that cellulite is NOT a disease. It is easy to spot cellulite as it appears as little “dimples” or “pockets” in the skin which give the skin a lumpy, bumpy or “orange peel” effect. The areas most involved are on the buttocks and thighs but the arms and abdomen can also be affected. Cellulite is more common in women than men and often begins at puberty suggesting a hormonal basis to some extent. In some studies, cellulite to some degree is present in almost 90% of women.
Cellulite is also known as adiposis edematosa, dermopanniculosis deformans, status protrusus cutis, and gynoid lipodystrophy. Cellulite is created in the subcutenous lays of the skin where capillaries, lymphatics, structural “fibrous” tissue, waters and emulsified fat interact. There appears to be some defect in the structural fibrous tissue architecture extending from muscle layers to the dermis which causes trapping or water and fat in small circular areas or cells. Contraction of the supporting fibrous strands results in the dimpling effect of cellulite.
While overweight and obese people commonly have cellulite, many people with cellulite are not overweight or have excess body fat. Indeed, the fat contained in the trapped areas is not inside adipose or fat cells. It is mainly liquid fat, water and other substances which form a “puddle” trapped by fibrous tissue.
While people who have cellulite are often perfectly healthy, medical conditions such as obesity, poor circulation, lymphatic flow impairment, and impaired detoxification mechanisms are thought to play a significant role. Stasis of lymphatic flow caused by inactivity, immobility and general low exercise habits are also thought to play a role in the severity of cellulite. Some studies point to nutritional factors.
Cellulite has many classification scales. In the Verjú study, the classification used to define baseline and post treatment status of cellulite was called the Nurnberger-Muller scale.
If you would like to learn more about the Verjú Laser and see if you are a candidate for treatment, contact the Nu-living Optimal Wellness and Longevity Center at 703-379-7110, or complete our getting started form here.
In 2002 the results of a landmark and controversial clinical study known as The Women’s Health Initiative, or the WHI were reported. This study had enrolled older women (average age 63) who were many years past their menopause to assess the answers to very specific questions regarding the risks and benefits associated with hormone therapy (HT) for women after menopause.
The WHI was notable for its size with about 16,000 women participating and being divided into 2 study groups. Group 1 consisted of about 8000 women within an intact uterus.They were given a combined oral conjugated estrogen and a synthetic progestin known as Prempro. In group 2 the women had had an hysterectomy and were only given an oral conjugated estrogen known as Premarin without the progestin. There was a control group of women who were given a placebo without any hormone. Both Prempro and Premarin are not bio-identical hormones as the estrogen comes from horses and the progestin is completely synthetic. The term “bio-identical” refers to the same exact estrogen found in women such as estradiol or the progestin progesterone.
Prior to the WHI, physicians strongly believed that HT (bioidentical or not ) protected women from heart attacks, strokes and dementia over the long run. Concern over risks such as breast cancer and blood clots were down played mainly because earlier results of a large scale epidemiologic study of relatively young nurses. These healthy young women entering their perimenopause and menopause had started HT (not bioidentical) in their late 40s or early 50s for symptoms such as hot flashes, sleeplessness, poor memory and reduced quality of life. After initiating HT, yearly reports about their health and quality of life were collected. The results were impressive. The nurses seemed free of any chronic diseases such as diabetes, hypertension, high cholesterol or arthritis and they were quite active and vital. The nurses reported minimal side effects or serious illness.
The results of the WHI had a major impact on clinical practice as the study reported there was no heart attack, stroke or dementia protection in the women given HT in both groups 1 and 2. In group 1 there was a small increase in breast cancer compared to the control group. Interestingly in group 2, comprised of the hysterectomized women given estrogen only, there was actually a 33 percent decrease in breast cancer ( yes even with the non bioidentical estrogen ). Both groups seemed to have increased blood clots and both had some benefit in the form of bone protection against post menopausal osteoporosis and colon cancer.
Nevertheless, NIH stopped the group 1 study citing the lack of benefit in the presence of increased blood clots and breast cancer. However NIH also allowed the group 2 to continue as there had been a decrease in breast cancer. Unfortunately so many women in group 2 were alarmed at the scary and sensational reporting over the findings in group 1 pertaining to breast cancer that many women in group 2 dropped out of the study. With the members of study group 2 now down to an insignificant number, NIH closed it down the following year.
Following the results of the WHI, many doctors and medical specialty organizations advised against the use of HT for women at menopause believing HT to be more risky than helpful in most situations.
While the hormone treatments in the WHI were not bioidentical, the FDA applied the same warning label to bioidentical hormones considering all forms of estrogen and all progestin’s to be equally dangerous and on beneficial as those studied in the WHI. This is another controversial area related to the results of the WHI i.e. to the results of clinical studies using non-bioidentical hormones apply to bioidentical hormones?
The intense media reporting, much of it inaccurate, created great anxiety among women. This led to a 70% World-wide decline of menopausal HT with almost universal recommendations from physicians and medical specialty organizations for women to avoid HT if possible or use HT at the lowest dose and for the shortest amount of time. Following the 2002 WHI results, a generation of doctors, doctors in training, medical students and allied health personnel were “warned “ not to advise women there were any long term health benefits associated with menopausal HT.
Despite the widespread opinion from health professionals following the WHI results for women to avoid HT due to high risks without counterbalancing benefit, some doctors remained skeptical of the complete turnaround in recommending HT for women at menopause. Why had the younger nurses followed yearly shown health benefits without medical side effects? Could there be a difference in risk/benefit of HT when it was given to younger women closer to their natural menopause as opposed to women who were older and often 15-20 years removed from their menopause?
NIH was asked for data on women in the study groups who were relatively young and it took over 5 years for NIH to finally analyze this subgroup of women in the WHI who were between 50-59 years old. In fact this age group did demonstrate cardiovascular protection with the use of HT. This new revelation led to the so-called “window of opportunity” theory which proposed that estrogen did provide cardiovascular protection as long as it was given within 10 years of woman’s natural menopause.
Over the past 13 years since the WHI, the breast cancer issue has diminished as a concern as reanalysis of the original data by NIH suggested there was no statistical increase in breast cancer in the study group 1 compared to the control group. This combined with emerging recognition of cardiovascular protection of HT use for younger women has turned the results of the WHI upside down. Moreover, women who had been treated with estrogen only, showed an actual decrease in breast cancer rates. In recent years the focus on a possible culprit for breast cancer in the WHI study group 1 pointed towards the synthetic progestin in Prempro as a possible cause of increased breast cancer occurrence. The synthetic progestin is known as methoxy progesterone acetate or MPA or Provera. A large study group in France using bioidentical progesterone in women demonstrated no increased in breast cancer in women on HT for over 10 years.
The incidence of blood clots seems also related to the type and method of estrogen administration. Taking estrogen through the skin or transdermally has been shown to be safe compared to oral estrogen which is associated with the risk of blood clots. The WHI used oral estrogen and in the study groups. Of note, only estradiol, a bioidentical estrogen, can be applied to the skin while the non-bioidentical estrogen, Premarin, must be swallowed. Here may also be another advantage of using bioidentical hormones.
Several recent large European epidemiological studies of women on HT around the start of their menopause or within the “window of opportunity”have demonstrated impressive cardiovascular disease protection compared to women who did not use HT at menopause. The studies used bioidentical estradiol however one study also employed the synthetic progestin MPA. Similarly, recent epidemiological studies are now emerging suggesting HT is protective against dementia. Women are affected by Alzheimer’s 3-1 compared to men and the incidence of dementia is increasing every year as women are living longer. Irrational fear of HT at menopause or physician unwillingness to recommend HT may be depriving women of crucial treatments protecting their long term health.
Dr. Terlinsky has been a member of the Endocrine Society and the North American Menopause Society (NAMS) for over 10 years. Attending annual meetings and focusing on the developments in HT for women over the past 13 years has been a major interest of his and it has kept him up to date with respect to developments in the field. Dr. Terlinsky vividly remembers the beginning of the “nuclear winter” for HT following the WHI. He has seen and read the initial post WHI guidelines from such respected medical organizations as the American College of Obstetrics and Gynecology, The Endocrine Society, the American Association of Clinical Endocrinologists, the American College of Physicians, International Menopause Society, the North American Menopause Society (NAMS), and U.S. Preventive Services Task Force. Those initial 2002-2003 guidelines were virtually in lockstep with one another with the exception of the International Menopause Society as they proclaimed HT was dangerous and had little benefit. The International Menopause Society has always been skeptical of the dire findings associated with HT which came from the WHI. It has been recommending the use of HT for long-term health benefits for women since at least 2011.
Dr. Terlinsky is cognizant of the revisions in guidelines for HT for women made by many of the above-mentioned medical organizations over the years since 2002 as new research information has accumulated. With the exception of the International Menopause Society none of the above-mentioned societies has openly reversed their position about advising HT for women at menopause for long-term health benefit.
But there is breaking news on the HT front. Data from Finland was presented at the most recent North American Menopause meeting once again demonstrating long-term benefit for women who take HT at menopause. The North American Menopause Society is likely to change its position on the use of HT for long-term benefit as the “nuclear winter” of hormone therapy slowly lifts. It is expected that the North American Menopause Society will likely join the International Menopause Society in recommending hormone therapy for some women for long-term health benefit and chronic disease prevention particularly if hormone therapy is started within the “ window of opportunity” years mentioned above. Those new recommendations are likely to be issued in early 2016.
Unfortunately, many physicians and allied health care providers have been discouraging women from taking hormones for years, and an entire generation of providers has been trained and indoctrinated into being, “anti-hormone”. This has caused women to be offered advice that is not based on current, up to date information regarding menopause hormone therapy. A good example of the unintended consequences of the 2002 post WHI entrenched recommendations today is the published data which estimates an extra 70,000 postmenopausal osteoporotic bone fractures annually that could have been prevented by hormonal treatment for osteoporosis protection. Many women with fractures had declined hormone therapy at their menopause on account of fear which was not counted by current information from the providers. As mentioned above emerging data also suggests women are allowing themselves to be at a much higher risk of dementia, stroke, and heart attack by not considering hormone therapy at menopause.
The real problem is another long-term large prospective trial as needed to once again assess recommending and providing women with hormone therapy at menopause and observing the beneficial effects over decades. That trial also needs to answer the question of whether bioidentical hormones hold advantages over synthetic hormone. For a variety of reasons this is unlikely to occur so that physicians who want to offer women the very best recommendations regarding hormone therapy must provide menopausal women with the best current data along with a scientific explanation of the preponderance of evidence that is now available. In subsequent articles on his website Dr. Terlinsly will explore other related topics dealing with menopausal hormone therapy.
There are many reasons for one to get a hormone test. Perhaps you have been displaying symptoms of hormonal imbalance. Maybe you just got pregnant, for instance. You could just want the information to maintain the proper homeostasis for your body. Whatever your reason to get a hormone test, it is a good one. Hormones are very important to regulating our bodies, day in and day out. They are needed to keep us at our best and bring us back when we are at our worst. Men and women both can get a hormone test to make sure they are at their optimal levels.
Your hormone levels are as individual as your fingerprint. No two people have the same exact levels and therefore it is important when getting a hormone test that the medical professional has experience. There are several main hormones that get tested and they all play integral parts in our lives. The main hormones tested are estrogen, progesterone, testosterone, DHEA, and cortisol. These five hormones contain a lot of information about you including deficiencies, excesses, and daily patterns. For example, cortisol levels differ throughout the day, they are normally higher in the morning and dwindle at night.
When getting a hormone test for estrogen you are actually getting a hormone test of the three estrogens; estradiol, estriol, and estrone. Men and women both produce estrogens. Estradiol is the type of estrogen tested in women who are not pregnant and the levels will vary during a menstrual cycle. Estriol is normally only measured during pregnancy because that is when those levels are highest and will continue to rise throughout the pregnancy. Estrone is measured in women who have gone through menopause or in men and women who might have cancer in their ovaries, testicles or adrenal glands.
You may need to get a progesterone hormone test for infertility or for tracking ovulation. Progesterone is produced in high levels during pregnancy, starting during the first trimester and continuing until the baby is born. Getting a hormone test for progesterone may also help assess the risk of a miscarriage. It may also help diagnose problems with your adrenal glands and some types of cancer in both men and women.
Testosterone is very important to men and women. Though the level of this hormone is much smaller in women than men it still plays an important role. It affects the brain, sexual functioning, genital tissues, and your energy levels, among other things. Testosterone may affect a man’s ability to have a baby which is one of the reasons why a man might choose this hormone test. He might also be losing his sex drive which is linked to testosterone. High levels of testosterone in a woman might cause her to take on male attributes such as facial hair. Getting a testosterone hormone test might also help find the cause of osteoporosis in men. DHEA is linked to testosterone so often times the two hormones are linked in their tests. DHEA levels can be linked to delayed puberty, Cushing’s Disease (a type of Cushing’s Syndrome), and adrenal gland tumors.
You may need to get a hormone test for cortisol if there is a potential problem with your pituitary gland. This could be either making too much or making too little. Adrenal fatigue happens when your body is not making enough cortisol because it has been in a high stress situation for too long. Cortisol levels change through the day and they are highest in the morning. The changing levels of cortisol are very important and if your cortisol levels maintain a high level it is known as Cushing’s Syndrome. If your doctor thinks that you are producing too much they would perform the test later in the day, if they don’t think you’re making enough the test will happen in the morning. Either way, you will likely be asked to avoid too much activity the day before.
Endocrine diseases or disorders would be more of a proper term for hormonal imbalance. There are three broad categories of endocrine diseases; hypo-secretion (lack of), hypersecretion (too much), and tumors on the endocrine glands. But how does this affect men? Or women? What are some signs or symptoms of a hormonal imbalance? What is hormonal imbalance to me or you?
Sometimes, a hormonal imbalance can have similar signs as aging and therefore can be confused quite easily. Some of the signs can be memory loss, muscle loss or weakness, erectile dysfunction, hair loss, depression, and many others. Andropause (also known as male menopause or androgen decline) is a decline in testosterone. However, there is no defined period of time that a man might go through these changes. Symptoms may include weakness, depression, and fatigue. Andropause is still somewhat controversial in the medical community because it isn’t as well defined as menopause. Often times this imbalance can be treated with testosterone replacement therapy and that will also help with the symptoms but does come with risks. Make sure to ask questions about any symptoms you might be having and have an open, honest conversation with your doctor about it. There are many other hormonal imbalances a man might experience in his life, andropause is just an example.
Well, we talked about andropause so why not touch on menopause. Menopause, basically, is the sign that a woman is leaving her reproductive age and is the gradual discontinuation of estrogen. Symptoms include hot flashes, mood swings, and if you are undergoing premature menopause (many experts consider it premature menopause if you are experiencing it before the age of 40) you may have other physical and emotional hurdles coming your way.
To be honest, women can experience many hormonal imbalances. She can experience hormonal imbalances during and after pregnancy. She can also experience them while menstruating. It is often a case of an improper relationship with the hormones progesterone and estrogen. If a woman ignores any signs or symptoms of a hormonal imbalance it can lead to some serious health issues, so be sure to consult a health professional. Sometimes when women have hormonal imbalances they will grow facial hair or thicker hair on their extremities.
Can the same things affect both genders? The answer is yes. Things like environment, stress, and nutrition can affect men and women and cause hormonal imbalance. Hormones regulate the human body in many ways and need to work together to maintain homeostasis. Adrenal fatigue is being discussed more in the medical community and happens when people are in high stress situations for long periods of time. It happens when your glands are no longer able to maintain your needed levels of cortisol. Ingesting certain types of foods en mass can also cause imbalances in men and women. And too much pollution in anyone’s environment is bad.
We all want to feel good about ourselves and we’re always looking for ways to make sure we can achieve our goals. There are many different body sculpting methods out there, from wraps to intrusive procedures, which can take you out of commission for days, weeks, or even months. There has to be a middle ground in there somewhere. Thanks to a lot of research and many painstaking hours of testing we have that middle ground and it is called lipo light body sculpting. In this article you will learn what lipo light body sculpting is and how it works, in a brief overview.
Lipo light body sculpting is one of the most recent discoveries utilizing light to speed up the process your body naturally uses to burn fat. When combined with exercise, lipo light becomes a very effective way to lose inches off your body. Lipo light uses up to sixteen pads that are placed directly on the skin to achieve the best results. Treatment times are about forty minutes long and take place over a four week period. It is recommended that you receive these treatments twice a week over that time period and follow your treatments up with exercise to continue to show results. After the initial lipo light body sculpting treatment period it is necessary that you then choose one of two follow up treatment paths: The first is that you continue to receive maintenance treatments up to twice a week or move onto another part of the body to sculpt. You can also combine the lipo light treatment with the Zerona cold laser treatment to employ the unique benefits of both body contouring therapies.
Lipo light body sculpting works by using light to target Chromophores. Chromophores are part of a molecule that has the ability to absorb certain types of visible light wavelengths. Some of those light wavelengths cause the fat cell to become permeable by changing the cells round shape. This light creates what is known as photobiomodulation. Photobiomodulation is becoming an applicable therapy for many different things in medical as well as veterinary fields because it causes cell stimulation to get clinical benefits. For lipo light body sculpting the cells that are targeted are the adipose cells which then release and break down the fatty acids and turn them into glycerol. Glycerol is what gives you energy which is why it’s important to exercise. The exercise will also help your blood circulate better therefore resulting in a better outcome from your therapy.
With the aid of lipo light body sculpting, exercise, and sticking to your treatment regimen you can achieve your body appearance goals. Be sure to stay hydrated during treatment periods and get your rest. You can find some more excellent information about lipo light here. With the help of lipo light you can look and feel your absolute best and you deserve that. Be sure to contact your local lipo light professional for more information and to find out if this is the right treatment for you and your lifestyle.
The Nu-Living HCG Diet is designed to provide speedy weight and metabolism correction that lasts. Through the use of an HCG injection phase and a very low calorie diet, patients have noticed daily results. While every situation is unique and there are many variables that affect the results, such as total caloric intake and exercise level, the Nu-Living HCG Diet has shown to be an overall highly effective weight and metabolism correction program. Individual weight loss results may vary depending on the specific very low calorie diet (VLCD) prescribed and on the patient’s adherence to the dietary instructions, but many patients experience day-to-day results during the HCG injection phase of the program (using a diet of 500-600 calories). This healthy and fit weight loss may occur for 3 to 6 weeks depending on the patient’s unique circumstances, along with current condition of health and specific body weight goals. Essentially, the weight loss occurring with the HCG diet depends on a patient’s starting point, caloric intake, exercise routine and level of compliance with the diet requirements. It is common for our patients to lose anywhere from 15-40 lbs. during the 6 weeks of the HCG injection phase. Guided by strict medical supervision of Dr.Terlinsky, it is not unusual for some people with an intake of 500-600 calories per day to experience noticable results in the first week alone!
By using a safe HCG injection in combination with enhanced nutrient fortification and a personally prescribed VLCD, the NU-Living HCG Diet promotes high maintenance of lean muscle tissue and the reduction of high-risk, excess body fat. Hunger can be significantly and noticeably reduced with maintained vivacity using this safe and scientifically valid program. Dr.Terlinsky has a passion for providing the very best health solutions for each and every patient he treats, and this is shown with his personalized approach to treatment with the HCG Diet and HCG injection. He consults with each patient to learn the personal and unique particularities of his/her situation in order to prescribe the healthiest, most effective Diet and HCG injection schedule possible. Particularly long-term results may be achieved with Nu-Living’s modified HCG diet. This consists of a high protein VLCD in the range of 800-1000 calories per day which can produce a vigorous weight loss each week during the HCG injection phase of the program. This less strenuous VLCD in the 800-1000 calorie daily range may provide weekly weight loss and is also the most popular choice of our HCG injection patients. Dr.Terlinsky presents a spectrum of VLCD diet choices during the first office visit for his patients to use with the HCG injection. This helps ensure that each and every patient is prescribed the correct program plan that works the best for his/her individual situation, maximizing results.
Because of the many factors involved in the prescription and selection of the correct HCG injection schedule and VLCD plan, Dr.Terlinsky believes that the best way to get started with the Nu-Living HCG Diet is to have a short phone conversation to briefly discuss the patient’s current health status. This will help define the appropriate program and diet in order to provide the optimal results for each patient.
Upon completing individualized goals, patients may transition into weight maintenance, with the knowledge of nutrition and exercise requirements, as well as behavioral modification strategies that can help you manage your weight for the long term. You will receive new information at this point that is specific to your lifestyle, and you may at this point have your metabolic resting rate re-measured.
It’s important to note that maintaining your goal weight is half of the weight loss process. When developing a long-term weight maintenance plan, you and your physician will find a solution that works best for you and your individual needs. For example, you may choose to discontinue taking appetite suppressants and explore new creative cooking ideas or develop more intensive exercises that help keep you at your goal weight.
